INTELLECTUAL PROPERTY LICENSING RIGHTS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Oct. 12, 2018 |
Aug. 20, 2018 |
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Naltrexone Implant Formulation [Member] | Australia from Trinity Compound Solutions [Member] | ||||||
Cash paid for acquisition | $ 10,000 | |||||
Aggregate purchase price, Shares | 20,000 | |||||
Aggregate purchase price, value | $ 236,000 | |||||
Patent acquired | $ 15,200 | |||||
Patents [Member] | ||||||
Amortization expense | $ 295 | $ 292 | ||||
Estimated useful lives | 13 years | |||||
Accumulated amortization | 2,931 | |||||
Intellectual Property [Member] | ||||||
Amortization expense | $ 13,795 | $ 11,790 | $ 47,160 | $ 11,990 | ||
Estimated useful lives | 5 years | |||||
Accumulated amortization | $ 70,940 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition The net cash inflow or outflow associated with the aggregate amount of adjustment to the purchase price of a previous acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|